Novabloc Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$10M
- Investors
-
5
Novabloc General Information
Description
Developer of a non opioid neuromodulation therapy designed to advance postsurgical pain management without dependence on narcotics. The company's platform offers targeted electrical stimulation, sustained analgesic effect, and preservation of motor control, enabling surgical patients and care teams improved recovery with reduced medication reliance.
Contact Information
Website
www.novabloc.comCorporate Office
- 223 Roswell Street
- Alpharetta, GA 30009
- United States
Corporate Office
- 223 Roswell Street
- Alpharetta, GA 30009
- United States
Novabloc Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 18-Nov-2024 | $10M | Completed | Clinical Trials - General | ||
| 2. Accelerator/Incubator | Completed | Clinical Trials - General | ||||
| 1. Spin-Off | 01-Jan-2023 | Completed | Clinical Trials - General |
Novabloc Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Novabloc Patents
Novabloc Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11623091-B2 | Portable electrical stimulation system and method | Active | 13-Feb-2019 | ||
| US-20200254257-A1 | Portable electrical stimulation system and method | Active | 13-Feb-2019 | ||
| US-10828491-B2 | Device and method to selectively and reversibly modulate a nervous system structure to inhibit pain | Active | 07-Dec-2018 | ||
| US-11202909-B2 | Device and method to selectively and reversibly modulate a nervous system structure to inhibit pain | Active | 07-Dec-2018 | ||
| US-11446498-B2 | Device and method to selectively and reversibly modulate a nervous system structure to inhibit pain | Active | 07-Dec-2018 | A61N1/36071 |
Novabloc Signals
Novabloc Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hatteras Venture Partners | Venture Capital | Minority | ||
| Portal Innovations | Venture Capital | Minority | ||
| UNC Health Ventures | Corporate Venture Capital | Minority | ||
| UNC REX Healthcare | Corporation | Minority | ||
| Tech North Atlanta | Accelerator/Incubator |
Novabloc FAQs
-
When was Novabloc founded?
Novabloc was founded in 2023.
-
Where is Novabloc headquartered?
Novabloc is headquartered in Alpharetta, GA.
-
What is the size of Novabloc?
Novabloc has 5 total employees.
-
What industry is Novabloc in?
Novabloc’s primary industry is Therapeutic Devices.
-
Is Novabloc a private or public company?
Novabloc is a Private company.
-
What is the current valuation of Novabloc?
The current valuation of Novabloc is .
-
What is Novabloc’s current revenue?
The current revenue for Novabloc is .
-
How much funding has Novabloc raised over time?
Novabloc has raised $10M.
-
Who are Novabloc’s investors?
Hatteras Venture Partners, Portal Innovations, UNC Health Ventures, UNC REX Healthcare, and Tech North Atlanta have invested in Novabloc.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process